Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
12,957 total articles
AirJoule Technologies announced the launch and commissioning of its AirJoule Prime system at the Newark, Delaware facility. The system is designed to generate up to 2,000 liters of pure distilled water per day by utilizing low-grade waste heat, targeting applications in industrial facilities, data centers, military operations, and water-scarce comm…
POET Technologies provided an update on its ongoing production ramp-up targeting volume shipments starting in the second half of 2026 and expansion to meet demand of up to 1 million units per month by the end of 2027. The company raised substantial capital to support growth, has multiple active customer engagements exceeding $100 million in potenti…
Catalyst Pharmaceuticals reported positive topline results from a Phase 1 clinical study showing that vamorolone provides balanced glucocorticoid activity with effective cortisol suppression but without significant immunosuppressive effects at clinical doses, supporting its potential use to treat a range of chronic inflammatory rare diseases. The s…
Gentex Corporation will release its second quarter 2026 financial results on July 24, 2026, before market open and host a conference call to discuss the results with the investment community. The event will be accessible via live audio webcast for public participants. Replays will be available after the call.
Quince Therapeutics, a clinical stage biopharmaceutical company (Nasdaq: QNCX), announces the establishment of a Scientific Advisory Board composed of leading pulmonary medicine experts to support the advancement of LAM-001, an inhaled rapamycin formulation targeting serious pulmonary conditions such as PH-ILD, BOS, and SAPH. The company plans Phas…
Upexi, Inc., a NASDAQ-listed digital asset treasury company focused on Solana, has partnered with Blueprint, an institutional-grade staking and digital-asset infrastructure provider, to stake a portion of its Solana holdings. This strategic partnership aims to leverage Blueprint's high-performance validator infrastructure to enhance yield and suppo…
WW International, Inc. announced that its Med+ program will support Medicare beneficiaries in accessing GLP-1 weight loss medications through the Medicare GLP-1 Bridge Program. This initiative offers eligible Medicare members medications like Wegovy and Zepbound at $50 per month from July 2026 to December 2027, combined with behavioral support and …
Genelux Corporation announced publication of translational analyses from its Phase 1b/2 VIRO-15 trial showing that Olvi-Vec, an oncolytic immunotherapy, modulates the tumor microenvironment and restores platinum chemotherapy sensitivity in platinum-resistant/refractory ovarian cancer. These findings provide mechanistic support for clinical benefits…
Cogent Biosciences has submitted a New Drug Application (NDA) to the FDA for bezuclastinib to treat Advanced Systemic Mastocytosis (AdvSM), based on positive data from the pivotal APEX trial demonstrating a 65% objective response rate and a favorable safety profile. This submission marks the company's third NDA for bezuclastinib in six months, with…
Innventure, an industrial growth conglomerate listed on NASDAQ under ticker INV, announces that Dr. Bill Grieco will succeed Bill Haskell as CEO effective October 1, 2026. The leadership transition follows a comprehensive search and reflects an emphasis on continuity and growth. Dr. Grieco brings strong internal experience and a history of leading …
Monopar Therapeutics announced that the FDA has granted Rare Pediatric Disease designation to its late-stage drug candidate ALXN1840 for treating Wilson disease, a rare genetic disorder causing toxic copper accumulation. This designation could lead to priority review vouchers, accelerating future drug approvals or providing financial benefits. ALXN…
Sharplink, Inc., a Nasdaq-listed company focused on Ethereum treasury management, announced the purchase of 10,000 ETH, increasing total ETH holdings to 886,725, alongside repurchasing over 2.1 million shares as part of its ongoing stock buyback program. The company also raised $75 million through a direct offering to support its ETH accumulation s…
Kaltura has been recognized by Gartner in its 2026 Market Guide for Meeting Solutions, highlighting its strength as an enterprise-grade platform for virtual meetings, classrooms, and digital experiences. The company's agentic AI-driven meeting tools enable real-time, personalized engagement and content delivery, enhancing communication and knowledg…
Biodexa Pharmaceuticals PLC announced the pricing of a $3.5 million funding package, including a registered direct offering and concurrent private placement of pre-funded warrants and warrants. The proceeds will support ongoing clinical development of its biopharmaceutical pipeline targeting diseases with unmet medical needs, including cancer and d…
Allarity Therapeutics announced the granting of a key U.S. patent by the USPTO for its stenoparib-specific Drug Response Predictor (DRP®) companion diagnostic, providing exclusivity for the combined use of stenoparib with the DRP® until April 2042. This intellectual property milestone supports the company's strategy for advancing precision medicine…
Aduro Clean Technologies announced a Memorandum of Understanding with AstroTurf to evaluate the use of Aduro's Hydrochemolytic™ Technology in recycling polyethylene and polypropylene components of synthetic turf. The collaboration aims to develop a technical and economic pathway for recovering valuable plastics from end-of-life synthetic turf, supp…
Genius Group Limited disclosed that its investors have initiated a class action lawsuit against Citadel Securities LLC and Virtu Americas LLC for alleged long-running market manipulation involving spoofing and naked short selling of Genius Group shares. The company reports over $250 million in damages due to these actions and plans to join the laws…
VisionWave Holdings, a U.S. defense technology company, announced a definitive agreement to acquire a 51% controlling stake in Meteor Aerospace Ltd., an Israeli aerospace and defense company known for advanced unmanned systems and integrated national security technologies. The acquisition, subject to customary closing conditions including flight va…
MediciNova, a clinical-stage biopharmaceutical company, reports significant progress including completion of the last patient visit in its Phase 2 trial for MN-001 targeting NAFLD associated with type 2 diabetes, advances in the Phase 3 ALS trial with MN-166, and receipt of a U.S. patent allowance for combination therapy in glioblastoma. The compan…
Leonardo DRS, Inc., a defense technology company, announced it will hold a conference call on July 30, 2026, to discuss its second quarter 2026 financial results. The earnings press release and supplemental information will be available on the investor relations website. The company specializes in advanced defense solutions for U.S. national securi…
SCYNEXIS, Inc. has initiated a Phase 1 clinical study for SCY-770, a novel and potent oral AMPK activator aimed at treating Autosomal Dominant Polycystic Kidney Disease (ADPKD). The study will evaluate food effects and pharmacokinetics to support dose selection for a Phase 2 proof-of-concept trial expected to begin in Q4 2026. SCY-770 has shown pro…
Akebia Therapeutics and U.S. Renal Care announced the early termination of the VOICE trial after interim analysis demonstrated Vafseo (vadadustat), administered three times weekly, provided statistically significant and clinically meaningful safety benefits for patients with anemia due to chronic kidney disease on dialysis compared to erythropoiesi…
Lands' End announced the appointment of Charlie Cole as CEO, succeeding Andrew McLean, who will transition to an advisory role. Cole brings extensive experience in consumer brands, digital transformation, and AI, aiming to build upon recent strategic progress and drive future growth. The company highlighted a $100 million share repurchase program r…
Teamshares Inc., a tech-enabled acquiror of small and medium-sized enterprises (SMEs), will present at the 26th Annual CJS New Ideas Summer Conference on July 9, 2026. The presentation will be led by CFO Brian Gaebe and Head of Capital Markets Nile Corso. The company focuses on acquiring SMEs from retiring owners and integrating them into its platf…
Enphase Energy has joined the Open Compute Project as a Platinum member to help develop open standards for next-generation AI data center power infrastructure, including advanced high-voltage DC power architectures. Leveraging its two decades of distributed power electronics experience and its newly developed IQ Solid-State Transformer technology, …
